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THE PESTICIDE REREGISTRATION PROCESS: COLLECTIONS OF HUMAN
HEALTH HAZARDS DATA FOR 3-CHLORO-P-TOLUIDINE
HYDROCHLORIDE (DRC-1339)
RAY T. STERNER, and DONALD J. ELIAS, U. S. Department of Agriculture, Animal and Plant Health Inspection
Service, Animal Damage Control, Denver Wildlife Research Center, Denver, Colorado 80225-0266
DANIEL R. CERVEN, MB Research Laboratories, Inc., Spinnerstown, Pennsylvania 18968
ABSTRACT: The 1988 Amendments to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) accelerated the
reregistration schedule for pesticide products registered with the Environmental Protection Agency (EPA) prior to 1984. The
compound 3-chloro-p-toluidine hydrochloride (DRC-1339), an avicide registered to control 14 pest bird species, was included
on Pesticide List B published by EPA. For the reregistration of DRC-1339,44 studies were required — 22 product chemistry,
7 wildlife/aquatic hazards, 8 human/domestic animal hazards, 5 environmental fate, and 2 residue chemistry studies. In 5 acute
human-health-hazards studies, DRC-1339 was found to: (1) have an oral LD50 of 330 (272-401) mg/kg in rats, (2) have a
dermal LD50 of >2.0 g/kg in rabbits, (3) cause corrosive effects to the eyes of rabbits, (4) cause corrosive effects to the skin of
rabbits, and (5) induce dermal sensitization in guinea pigs. Results support the current precautionary statements on the “use
labels” warning of harmful ingestion, inhalation, dermal absorption and eye irritation effects to users of the active ingredient.
Proc. 15th Vertebrate Pest Conf. (J. E. Borrecco & R. E. Marsh,
Editors) Published at University of Calif., Davis. 1992

(EPA 1991), and (3) a summary of 5 acute human-healthhazards studies submitted to the EPA in support of DRC1339 reregistration.

INTRODUCTION
The chemical 3-chloro-p-toluidine hydrochloride
(C7H9NCl2; DRC-1339) is an effective avicide that is used in
a pelleted bait marketed under the tradename Starlicide
Complete® by Purina Mills, Inc., St. Louis, MO (Besser et al.
1967, Decino et al. 1966, Schafer 1981). Because DRC-1339
is highly toxic (LD50<10 mg/kg) to most passerines,
columbids, and corvids but only moderately toxic (LD50 > 100
mg/kg) to most raptors and mammals, the chemical is considered selective for target species. Risks of primary or secondary hazards to non-target animals are low (Cunningham et al.
1981; Savarie and Schafer 1986, Schafer 1984).
The reregistration of DRC-1339 is a priority of the U. S.
Department of Agriculture (USDA), Animal and Plant Health
Inspection Service (APHIS), Animal Damage Control (ADC)
Program (Knittle et al. 1990). Purina Mills, Inc. and APHIS
currently have 2 Federal (FIFRA Section 3) and 28 State
(FIFRA Section 24C) registrations for the compound. These
cover 6 general applications, including pigeons on/near urban
structures or rural non-crop areas, gulls on/near coastal islands, blackbirds foraging on grain at livestock feedlots,
blackbirds at large roost-staging areas, corvids depredating
on newborn calves/lambs, and corvids foraging on endangered/threatened species. Altogether, 14 target species are
cited on the “use labels”; these include: pigeon (Columba
livid), herring gull (Larus argentatus), great black-backed gull
(Lams marinus), ring-billed gull (Larus delawarensis), common raven (Corvus corax), common crow (Corvus brachynchos), Brewer's blackbird (Euphagus cyanocephalus),
brownheaded cowbird (Molothrus ater), common grackle
(Quisculus quiscula), great-tailed grackle (Cassidix mexicanus), red-winged blackbird (Agelaius phoeniceus), starling
(Sturnus vulgaris), tricolored blackbird (Agelaius tricolor),
and blackbilled magpie (Pica pica).
This paper presents: (1) an overview of the FIFRA-1988
Process which directed the 9-year, 5-phase reregistration
schedule for pesticide products, (2) a description of the Code
of Federal Regulations (CFR) 40 (Parts 150-189) which established basic procedures for the conduct of pesticide tests

THE FIFRA-1988 PROCESS
DRC-1339 was originally registered in 1967 (Knittle et
al. 1990). Only minimal environmental safety and human
health hazards data were required at that time. The 1972
amendments to FIFRA, titled the Federal Environmental
Control Pesticide Act, mandated that all pesticides must meet
registration data requirements (be reregistered) within a 5year period (Fagerstone et al. 1990). EPA was directed to
reevaluate the environmental safety/human hazards associated with about 600 active ingredients and 45,000 formulated
products. Because of the magnitude of this task, progress by
EPA was slow. In 1988, Congress amended FIFRA to accelerate EPA's reregistration efforts. FIFRA-1988 required that
all pesticides containing an active ingredient first registered
prior to November 1,1984 must be reregistered within a 9year period in 5 phases.
Phase 1
In Phase 1 EPA issued 4 lists (A, B, C, D) of active
ingredients (A.I.) subject to reregistration. List A contained
194 groups of related pesticide active ingredients (350 specific A.I.) for which EPA had issued Registration Standards
before the effective date of FIFRA-1988. Remaining pesticides were divided into 3 lists (Lists B—229 A.I., C—288
A.I., and D—286 A.I.) based upon their potential for human
exposure and environmental risks. DRC-1339 appeared on
List B dated May 25,1989.
Phase 2
This phase gave registrants 90 days to notify EPA
whether or not they intended to reregister their active ingredients, to commit to providing necessary new studies, and to
pay newly imposed reregistration and maintenance fees
(Fagerstone 1990). Because the low-volume use of DRC1339 technical product (< 100 lbs./year) made it economically
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infeasible for Purina Mills, Inc. (the technical registrant) to
maintain the technical product registration, USDA/APHIS
formed an informal consortium with Purina to reregister
DRC-1339. Purina and USDA/APHIS mutually projected a
continued need for the compound as an agricultural avicide
and agreed to provide 22 product chemistry, 7 wildlife/aquatic
hazards, 8 human/domestic animal hazards, 5 environmental
fate, and 2 residue studies required to reregister the DRC1339 A.I.
Phase 3
Phase 3 required registrants to provide summaries of
existing studies that might be used to support reregistration,
to initiate new studies, and to identify known adverse effects.
For DRC-1339, no summaries of prior studies were submitted, but 44 new studies were initiated in Phase 2. To date, 39
of these studies have been completed and submitted to EPA.
Phase 4
During this Phase, EPA reviewed the data submitted. A
Data Call-In was received from EPA on February 25, 1991
identifying 13 additional studies of which 6 were ultimately
required (3 Product Chemistry, 1 Human/Domestic Animal
Hazards, and 2 Environmental Fate studies). These are included in the total studies cited under Phase 3.
Phase 5
In Phase 5 EPA will review all the submitted studies and
decide whether or not to reregister the active ingredient —
issue/not issue a "Registration Eligibility Document (RED)."
The EPA will also identify specific studies that will be needed
for reregistration of end-use products (the field formulations).
DATA REQUIREMENTS
40 CFR (Parts 150-189) specifies the types of chemical/
environmental/ human health hazards studies required for
pesticide registration or reregistration (EPA 1991). It also
defines technical terms and outlines Good Laboratory Practice (GLP) standards to be used in data collections. Twelve
“Subdivisions” to the Code specify the types of data to be
provided by the registrants) for an active ingredient (see
Figure 1). Each of these Subdivisions contains a matrix of the
studies required for the chemical's “general use pattern” (terrestrial: food/non-food crop; aquatic: food/non-food crop;
greenhouse: food/non-food crop; forestry; domestic outdoor;
and indoor) and “test substance” (manufacturing-use product
or end-use product).
The specific studies that compose Subdivision F (Hazards Evaluation: Human and Domestic Animals) are included
under 5 categories: Acute, Subchronic, Chronic, Mutagenicity, and Special Testing. In this paper, we present a summary
of 5 recently completed Acute Tests for DRC-1339: (1)
Acute Oral Toxicity—Rat (GRN 81-1), (2) Acute Dermal
Toxicity—Rabbit (GRN 81-2), (3) Primary Eye Irritation—
Rabbit (GRN 81-4), (4) Primary Dermal Irritation—Rabbit
(GRN 81-5), and (5) Dermal Sensitization—Guinea Pig
(GRN 81-6) (see Fig. 1).

Figure l. The 12 Subdivisions of tests presented in 40 CFR that
may be required to register/reregister a pesticide (top); and, the
acute data required for reregistration of DRC-1339 (Subdivision F-Hazard Evaluation: Humans and Domestic Animals)
under Phases 2 and 3 of FIFRA-1988 (see EPA 1991).

ards studies were required for reregistration of DRC-1339.
These studies were contracted to MB Research Laboratories,
Inc., Spinnerstown, PA. All studies adhered to Good Laboratory Practice provisions as specified in 40 CFR Part 160. Data
from these studies could impact the wording of precautionary
statements to human users of DRC-1339 included on the
pesticide “use labels.”
Acute Oral Toxicity—Rat
(Single Oral Dose LD50) (GRN 81-1)
Objective—This test was conducted to determine the
acute toxicity of DRC-1339 when administered via gavage as
a single oral dose to male and female albino rats (Rattus
norvegicus).
Methods—Following a quarantine period of at least 1
week, 5 healthy male and 5 female Wistar albino rats (each
approximately 8 weeks old and weighing between 200-300
g) were randomly assigned to each of 5 dose groups (247,
312, 500, and 1000 mg/kg); an additional group of 5 female
rats was tested at 277 mg/kg to further clarify the dose re-

ACUTE HUMAN-HEALTH-HAZARDS
STUDIES FOR DRC-1339
Based on negotiations between EPA, Purina Mills, Inc.,
and USDA/APHIS, the following 5 acute, human health haz-
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sponse function for that gender. The pre-test weight range
was 204-300 g for males and 212-253 g for females. The
weight variation of the animals did not exceed ±20% of the
mean weight. Rats were identified by cage notation and indelible body marks, and were housed 1/cage in suspended
wire mesh cages. Bedding was placed beneath the cages and
changed twice/week. Fresh Purina Rat Chow Diet #50121
(Purina Mills, Inc., St. Louis, MO) was provided ad libitum,
except for 16-20 h prior to dosing (fasted). Water was available ad libitum.
The animal room (reserved exclusively for rats on acute
tests) was temperature controlled (19-21° C), with a 12:12 h
light:dark (0600-1800 and 1800-0600 h) schedule. The test
substance (97.1% DRC-1339) was used as a 25% w/v dilution in distilled water for each dose level.
Each rat received the respective oral dose via gavage.
The rats were observed 1, 2, and 4 h post dose, and once daily
thereafter for 14 successive days to determine toxicity and
pharmacological effects. Each animal was observed twice
daily for mortality. Body weights were recorded immediately
pretest, weekly, and at death or study termination (survivors).
All animals were necropsied for gross pathology.
Results—Mortality (male:female) to the 5 doses was:
247 mg/kg (1:1), 277 (no males tested:l), 312 mg/kg (0:5),
500 mg/kg (4:5), and 1000 mg/kg (5:5). Deaths occurred by
Day 6 and were preceded by physical signs of lethargy, ataxia
(uncoordinated movements), muscle flaccidity, negative
righting reflex, chromodacryorrhea (reddish ocular discharge), ptosis (partial eyelid closure with constricted pupil),
piloerection, tachypnea (increased respiration rate),
chromorhinorrhea (colored discharge from nose), coma,
prostration, brown staining of bodily areas, and wetness of
the nose/mouth area. Necropsy of the dead rats revealed abnormalities of the lungs, liver, kidneys, urinary bladder, heart,
and gastrointestinal tract, as well as wetness and brown staining of the nose/mouth and anogenital areas.
Physical signs noted in survivors included: lethargy,
ataxia, piloerection, muscle flaccidity, tachypnea,
chromorhinorrhea, and wetness or brown staining of the nose/
mouth area. Body weight effects were minimal, however,
instances of weight loss or less than normal weight gain were
noted for several rats. The LD50 values (95% confidence intervals) were: males—350 (267-458) mg/kg, females — 303
(263-349) mg/kg, and males/females combined — 330 (272401) mg/kg of body weight (Litchfield and Wilcoxon 1949).
According to EPA toxicology criteria, DRC-1339 is a
Category II Toxicant (LD50 >50 but <500 mg/kg).

in suspended wire mesh cages. The rabbits were provided
fresh Purina Rabbit Chow Diet #5321 (Purina Mills, Inc., St.
Louis, MO) and water ad libitum. The animal room (reserved
exclusively for rabbits on acute tests) was temperature controlled (19-21° C); a 12:12 h light:dark schedule (0600-1800
and 1800-0600 h) was used. Approximately 24 h before application of the test substance (97.1% DRC-1339), a large
(10% of body surface) dorsal spot on the back of each rabbit
was shaved; the skin of each animal was checked and found
to be intact (unbroken) prior to test.
The DRC-1339 was moistened (made pasty) with distilled water, and applied onto the shaved dermal site, 1 time,
via syringe-type applicator. The dose was 2.0 g/kg of body
weight based upon the weight of the dry DRC-1339. The site
was then covered with a gauze patch, secured with non-irritating tape (gentle pressure was applied to the gauze to distribute the product over the covered site). The torso was then
wrapped with thin plastic to prevent rubbing/scratching of the
treated area and secured with non-irritating tape. At 24 h, the
patch was removed, and the residual DRC-1339 was washed
off the skin with water. Test sites for each rabbit were scored
for dermal irritation at 24 h post dose and on Days 7 and 14
using the Draize Dermal Scale (Draize 1944). Additional
toxic signs were also described.
Regarding general toxicity and pharmacological signs,
the rabbits were observed at 1, 2, and 4 h post dose and once
daily throughout the 14-day test. Each rabbit was observed
twice daily for mortality during this period. Body weights
were recorded pretest, weekly, and at termination of the test.
All rabbits were necropsied and examined for gross pathology upon completion of Day 14.
Results—All rabbits survived the 2.0 g/kg dermal application. Physical signs of diarrhea, few feces, and soiling of
the anogenital area were noted in some animals.
No rabbits showed changes in body weights. Dermal
reactions, slight to well-defined on Day 1, were absent to
severe by Day 14 (considerable variability observed). The
treated skin of all rabbits was stained orange at 24 h. Slight to
well-defined erythema (redness) was observed for 6 of 10
rabbits at 24 h, with 3 males eventually scored as severe by
Day 7; whereas, 2 males continued to be scored as having
severe erythema at Day 14. Edema (fluid production/drainage) was observed on all rabbits at 24 h, but then decreased to
slight edema on 4 rabbits at Day 7; no animals showed edema
on Day 14. Additional signs that were evident for at least a
portion of the rabbits were most frequent on Day 7 and included: orange skin, flaking skin, and shiny areas. Necropsies
revealed abnormalities of the treated skin, liver, kidneys, intestines, and urinary bladder; data for 1 rabbit (male) appeared “normal.”
The LD50 was determined to be >2.0 g/kg of body weight
—no deaths recorded. Thus, DRC-1339 is classed as a Category III Toxicant for dermal effects—>2000 mg/kg.

Acute Dermal Toxicity (LD50)—Rabbit (GRN 81-2)
Objective—This test was conducted to determine the
potential toxicity of DRC-1339 when applied dermally and
kept in contact with the skin of rabbits for 24 h.
Methods—Following a quarantine period of at least 1
week, 5 healthy male and 5 healthy female New Zealand
albino rabbits (Oryctolagus cuniculus) were randomly selected for test. The minimum and maximum pretest weights of
the rabbits were 2.3 to 2.4 kg (males) and 2.1 to 2.5 kg
(females). Animals were identified by cage notation and
uniquely numbered metal ear tags; they were housed 1/cage

Primary Eye Irritation—Rabbit (GRN 81-4)
Objective—The objective was to determine the irritation/corrosive effects of DRC-1339 when instilled into the
eyes of rabbits. This is a derivation of the well-known “Draize
Test” (Draize et al. 1944).
Methods—Following quarantine of at least 1 week, 6
healthy New Zealand albino rabbits (free from ocular irritation) were designated for test. Minimum and maximum pre-

1
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secured with adhesive tape to retard evaporation of volatile
substances. At the end of 4 h, the wrappings and gauze were
removed, and the site was washed gently with water to remove residual DRC-1339.
Rabbits were observed for skin reactions at 30 and 60
min after removal of the site coverings and at 24, 48, and 72 h
post removal. Erythema and edema were scored according to
the Draize Dermal Technique (Draize et. al. 1944). Dermal
irritation was defined as the production of reversible inflammatory changes to the skin; dermal corrosion referred to irreversible tissue damage to the skin. Ulceration, necrosis, and
possible tissue destruction were also observed. To determine
reversibility of DRC-1339 produced skin effects, measurements were made on Days 7 and 14.
Results—Dermal scores were variable for the 6 rabbits.
Erythema scores ranged from slight to moderate at 1 and 24 h
post patch removal and slight to severe at 48 and 72 h post
removal. Erythema remained slight to severe on Days 7 and
14. Edema was slight to moderate at 1 h post patch removal
but absent to well-defined throughout the remainder of the
test. Instances of moderate eschar (black areas and areas of
shiny skin indicative of injuries in depth) were noted during
the test. Instances of diarrhea for certain rabbits were the only
abnormal systemic signs noted.
Based on the observed “injuries in depth” (eschar) to
some rabbits, DRC-1339 is judged to be a Category I Toxicant for dermal effects following 4 h of contact — corrosive
(tissue destruction into the dermis or scarring for some animals).

test body weights of the rabbits were 2.3 and 2.5 kg, respectively. The rabbits were identified by cage notation and a
uniquely numbered metal ear tag. Rabbits were housed 1/
cage in suspended wire mesh cages located within a temperature-controlled (19-21° C) animal room that was reserved
exclusively for rabbits on acute tests with a 12:12 h (06001800 and 1800-0600 h) light:dark schedule in effect. Fresh
Purina Rabbit Chow Diet #5321 (Purina Mills, Inc., St. Louis,
MO) and water were provided ad libitum.
Approximately a 0.1 ml equivalent (mean of 54 mg) of
dry DRC-1339 (97.1%) was placed into the conjunctival sac
of 1 eye of each rabbit; the contralateral eye served as a
control. After instillation, the eyelids were held together for
approximately 1 sec; the eyes were not washed. Ocular responses were graded according to the Draize Scale (i.e.,
maximum scores of 80, 10 and 20 were possible for cornea,
iris, and conjunctivae, respectively); these were recorded at 1
h post instillation and on Days 1, 2, 3, and 7 of a scheduled
21-day test (Draize 1944). The eyes of each rabbit were examined using sodium fluorescein for the Day-1 grading of
corneal effects; sodium fluorescein penetrates corneal disturbances and shows the area of ocular effect during the early
observations. Reversible change to the eye was considered
evidence of irritation; irreversible tissue damage to the anterior surface of the eye was considered evidence of corrosion.
Results—Corneal opacity, iritis, and severe conjunctival irritation were noted in the test eyes of all 6 rabbits, and
these symptoms persisted through Day 7. Due to the severity
of the corneal, iris, and conjunctival reactions (corrosive effects) in all of the rabbits, the study was terminated on Day 8
of the test for “humaneness reasons.” An expert veterinary
ophthalmologist inspected the animals and prepared a detailed report to justify early termination. Diarrhea was the
only abnormal systemic sign noted during the observation
period.
The test substance (DRC-1339) is considered to be a
Category I Toxicant—corrosive (irreversible destruction of
ocular tissues) or corneal involvement or irritation persisting
for more than 21 days.

Dermal Sensitization — Guinea Pig (GRN 81-6)
Objective—The objective of this test was to determine
the potential of DRC-1339 to promote skin sensitization reactions after repeated topical “skin insult” applications in guinea
pigs.
Methods—Following quarantine of at least 5 days, 34
healthy male Hartley albino guinea pigs (Cavia cobaya) were
selected for the test. Pretest body weights of the animals were
between 355 and 400 g. Each guinea pig was identified by
specific cage notation and a uniquely numbered ear tag. The
animals were housed 1/cage in suspended rodent-type cages.
Fresh Purina Guinea Pig Chow Diet #5025 (Purina Mills,
Inc., St. Louis, MO) and water were available ad libitum. The
animals were maintained in a temperature-controlled (19-21°
C), light-/dark-controlled (0600-1800 and 1800-0600 h) room
that was reserved exclusively for guinea pigs on acute tests.
The test procedure used the Buehler Method. Prior to
initiation of the study, a topical preliminary screen was conducted using 4 guinea pigs. This was to determine a “mildly
irritating” and a “highest non-irritating” concentration of
DRC-1339. A dorsal area of about 5 by 10 cm on each animal
was clipped free of hair 24 h prior to test (skin unbroken).
Eight concentrations of DRC-1339 (0.1, 0.5, 1, 5, 10, 25, 50,
and 100%) were prepared using distilled water; the 100%
concentration was prepared by mixing the dry chemical with
a few drops of distilled water. Each animal received 4 concentrations of DRC-1339 (i.e., 1 at each of 4 sites/guinea pig).
Except for the 100% concentration, which was applied as a
paste and covered with a gauze patch, the concentrations
were placed onto the skin and covered with a 25-mm Hilltop
Chamber (a clear plastic cover). Finally, the sites were covered with a rubber dental dam large enough to span the 4

Primary Dermal Irritation—Rabbits (GRN 81-5)
Objective—This test was conducted to determine the
irritant or corrosive effects of DRC-1339 when applied
dermally and kept in contact with the skin of rabbits for 4 h.
Methods—Following at least 1 week of quarantine, 6
healthy New Zealand albino rabbits (approximately 8 weeks
old) were selected for this test. Pretest body weights of the
rabbits were between 2.1 and 2.4 kg. The rabbits were identified by cage notation and uniquely numbered metal ear tags.
Animals were housed I/cage in suspended wire mesh cages
located in a room reserved exclusively for rabbits on acute
tests. This room was temperature-controlled (19-21° C), with
a 12:12 h light:dark (0600-1800 and 1800-0600 h) schedule.
Body weights of each rabbit were recorded pretest.
Approximately 24 h prior to the application of DRC1339, about a 10 cm2 area on the dorsal trunk of each animal
was shaved; the site remained intact (unbroken) for all animals. On Day 1, 0.5 g of DRC-1339 (moistened with distilled
water to form a paste) was placed on the treated site of each
animal for 4 h. A gauze patch was place over the paste and
secured with non-irritating adhesive tape; the torso of the
rabbit was then wrapped with a semi-occlusive dressing and
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causes corrosive effects to the eyes of rabbits, (4) causes
corrosive effects to the skin of rabbits, and (5) induces dermal
sensitization in guinea pigs. The “precautionary statements”
for DRC-1339 contained in the upper left portion of pesticide
“use labels” currently read:
Harmful if swallowed, inhaled, or absorbed through
the skin. Avoid contact with eyes, skin, or clothing.
Handle only with protective gloves, clothing, and face
mask, or respirator. Wash hands with soap and water
after handling.
These precautions concur with the previously described
results.

sites. Two pieces of elastoplast tape were used to cover the
dam. The DRC-1339 remained in place for 6 h. Then, the
tape, dam, chambers, and gauze were removed; residual
DRC-1339 was washed away with distilled water and the
sites dried using soft toweling. The treated sites were examined and scored at 24 and 48 h post application using the
Draize Dermal Scoring Technique (Draize et al. 1944). Based
on irritation scores, the “mildly irritating concentration” chosen for the sensitization study was the 100% dose and the
“highest non-irritating concentration” was the 25% dose.
The main sensitization study involved 30 guinea pigs
assigned to 4 groups; these animals were housed, treated, and
prepared essentially the same as those in the preliminary
screen. The total study involved a 38-day sequence consisting
of a 21-day induction phase, a 14-day waiting phase, and a 3day challenge phase. Group 1 (n=10) received 3 topical inductions over a 3 week period of the “mildly irritating”
(100%) concentration. Group 2 (n=5) served as the non-induced control for DRC-1339; this Group would be tested
during the challenge phase only. Group 3 (n=10) served as a
“positive control”; this group was dosed with a 0.2% concentration of Dinitrochlorobenzene (DNCB) in the same manner
as the DRC-1339 animals—DNCB is a known dermal
senitizer. Finally, Group 4 (n=5) served as the non-induced
control for DNCB; this Group received applications of DNCB
only during the challenge phase. Skin reactions of guinea
pigs in Groups 1 and 3 were recorded at 24 and 48 h after
induction.
Two weeks after the third induction with DRC-1339 or
DNCB, Groups 1 and 2 were challenged with a 25% concentration of DRC-1339, and Groups 3 and 4 were challenged
with a 0.1% concentration of DNCB. Skin reactions of the
guinea pigs in each of the 4 groups were scored at 24, 48, and
72 h post challenge application.
Results—Erythema of the dermal sites was absent to
mild following Induction 1, mild to severe following Induction 2, and absent to mild following Induction 3. Edema was
absent to mild following Induction 1, slight to mild following
Induction 2, and absent to barely perceptible following
Induction 3.
During the challenge phase, positive responses were
noted in 7 of 10 DRC-1339-treated guinea pigs and 6 of 10
DNCB controls. Erythema ranged from barely perceptible
to mild at 24 h, absent to slight at 48 h, and absent to very
slight at 72 h for DRC-1339 animals. Edema, absent at 24 h,
was absent to slight in select animals by 48 h post challenge,
and absent to very slight at 72 h post challenge. There were
no positive responses to the challenge concentrations (25%
DRC-1339 or 0.1% DNCB) in the non-induced control
guinea pigs.
Due to the frequencies and severities of reactions during
the challenge phase, both DRC-1339 and DNCB are considered “dermal sensitizers.”

ACKNOWLEDGEMENTS
Our thanks to Craig Ramey and Kathleen Fagerstone for
critiques of the manuscript. Patricia Burk and Barbara Healzer
provided the word-processor versions of the paper.
LITERATURE CITED
BESSER, J. F., W. C. ROYALL, JR., and J. W. DEGRAZIO.
1967. Baiting starlings with DRC-1339 at a cattle feedlot. J. Wildl. Manage. 31(1):48-51.
CUNNINGHAM, D. J., E. W. SCHAFER, JR., and L. K.
McCONNELL. 1981. DRC-1339 and DRC-2698 residues in starlings: preliminary evaluation of their effects
on secondary hazard potential. Proc. Bird Control Seminar 8:65-70. Bowling Green, OH.
DECINO, T. J., D. J. CUNNINGHAM, and E. W.
SCHAFER, JR. 1966. Toxicity of DRC-1339 to starlings. J. Wildl. Manage. 30(2):249-253.
DRAIZE, J. H., G. WOODARD, and H. O. CALVARY.
1944. Methods for the study of irritation and toxicity of
substances applied topically to the skin and mucous
membranes. J. Pharmacol. Exp. Therap. 82:377-390.
ENVIRONMENTAL PROTECTION AGENCY. 1991.
Code of federal regulations: protection of the environment. 40 (Parts 150 to 189). U.S. Government Printing
Office: Washington, DC 674 pp.
FAGERSTONE, K. A., R. W. BULLARD, and C. A.
RAMEY. 1990. Politics and economics of maintaining pesticide registrations. Proc. Vertebr. Pest Conf.
14:8-11.
KNITTLE, C. E., E. W. SCHAFER, JR., and K. A.
FAGERSTONE. 1990. Status of compound DRC-1339
registrations. Proc. Vertebr. Pest Conf. 14:311-313.
LITCHFIELD, J. T., JR., and F. WILCOXON. 1949. A simplified method of evaluating dose-effect experiments. J.
Pharmacol. Exp. Therap. 96:99-113.
SAVARIE, P. J., and E. W. SCHAFER, JR. 1986.
Biodeterioration of Warfarin, sodium monofluoroacetate
(1080), 4-aminopyridine and 3-chloro-4-methylbcnzamine in terrestrial vertebrate pests. Pages 66-73 In:
S. Barry and D. R. Houghton, eds. Biodeterioration 6,
Proc. 6th Int. Biodeterioration Symp., CAB International,
London, U.K.
SCHAFER, E. W., JR. 1981. Bird control chemicals—nature, modes of action and toxicity. In: Handbook Series
in Agriculture. Vol. III, A. A. Hanson, Ed., CRC Press,
West Palm Beach, FL. pgs. 129-139.
SCHAFER, E. W., JR. 1984. Potential primary and secondary hazards of avicides. Proc. Vertebr. Pest Conf.
11:217-222.

CONCLUSIONS
Reregistration of DRC-1339 is progressing on schedule;
the 44 studies required to address potential adverse environmental/human-health effects will be completed in 1994. Results from the 5 acute studies conducted to provide data for
Subdivision F (40 CFR Part 158.34) Requirements showed
that DRC-1339: (1) has an oral LD50 of 330 (272-401) mg/kg
in rats, (2) has a dermal LD50 of >2.0 g/kg in rabbits, (3)
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